Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease

May 23, 2018

Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease

Published on 05/22/2018

previous post: [<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study
next post: Prognostic impact of tumour–stroma ratio in early-stage oral tongue cancers